Xanadu Quantum Technologies Ltd has filed a prospectus supplement to update its registration statement, reflecting recent developments in its operations. This filing is significant as it indicates ongoing efforts to enhance its quantum computing capabilities and secure funding for future projects.
Founded with a mission to build useful quantum computers, Xanadu operates in the electronic computers industry, specifically focusing on photonic quantum computing. The company’s shares are traded under the ticker symbol XNDU on both the Nasdaq and the Toronto Stock Exchange.
The filing dated November 12, 2026, serves to amend and supplement the prospectus dated June 1, 2026, which is part of the company’s Registration Statement on Form F-1. This prospectus supplement updates information included or incorporated by reference in the original prospectus with details from a recent Report on Form 6-K.
According to the filing, the Class B Subordinate Voting Shares of Xanadu are listed on the Nasdaq and TSX. As of November 11, 2026, the last reported sales prices were $2.80 on Nasdaq and C$3.95 on the TSX.
The prospectus supplement highlights the company’s ongoing efforts to address engineering challenges and enhance its technology. Dr. Christian Weedbrook, the Founder and CEO, noted, “Loss is the engineering challenge between Xanadu and a utility-scale quantum computer, and we continue to go after it from every direction.”
In addition, the company has been working on partnerships and investments to support its growth. For instance, the recent launch of Backline in collaboration with AMD is aimed at building the classical computing infrastructure necessary for utility-scale quantum computing.
The filing also outlines Xanadu’s financial performance, including a cash position of $286.5 million as of September 30, 2026. The company reported revenue of $1.3 million for the third quarter, a 32% increase year-over-year, driven mainly by DARPA QBI revenue and partnership engagements.
However, the company also reported a net loss of $32.2 million for the quarter, compared to a loss of $20.3 million in the same period last year. This was attributed to increased research and development expenses and general administrative costs.
Looking ahead, the filing indicates that Xanadu is focused on advancing its technology and expanding its partnerships. The company has secured government support, including a definitive agreement with the Government of Canada for approximately $140 million in funding for its new Inception facility.
As the electronic computers industry continues to evolve, Xanadu’s updates reflect a commitment to innovation and growth. The company’s efforts to enhance its quantum computing capabilities may position it favorably against competitors in the sector.
Details were not available in the SEC filing regarding what happens next for the company following this prospectus supplement.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










